| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
70,540,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
4,776,453 |
Avg
Vol: |
2,215,743 |
| 52
Week Range: |
$49.96 - $49.96 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Fletcher Robert C. |
V.P., Business Development |
• • – |
2014-01-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(48,878) |
0 |
|
- |
|
| Fletcher Robert C. |
V.P., Business Development |
• • – |
2014-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
48,878 |
48,878 |
|
- |
|
| Fletcher Robert C. |
V.P., Business Development |
• • – |
2014-01-24 |
4 |
D |
$50.00 |
$1,861,350 |
D/D |
(37,227) |
0 |
|
- |
|
| Doyle Thomas F |
VP Strategic Initiatives |
• • – |
2014-01-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(48,878) |
0 |
|
- |
|
| Doyle Thomas F |
VP Strategic Initiatives |
• • – |
2014-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
48,878 |
48,878 |
|
- |
|
| Doyle Thomas F |
VP Strategic Initiatives |
• • – |
2014-01-24 |
4 |
D |
$50.00 |
$5,604,450 |
D/D |
(112,089) |
0 |
|
- |
|
| Broom Colin Md |
VP & Chief Scientific Officer |
• • – |
2014-01-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(48,878) |
0 |
|
- |
|
| Broom Colin Md |
VP & Chief Scientific Officer |
• • – |
2014-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
48,878 |
48,878 |
|
- |
|
| Broom Colin Md |
VP & Chief Scientific Officer |
• • – |
2014-01-24 |
4 |
D |
$50.00 |
$7,702,900 |
D/D |
(154,058) |
0 |
|
- |
|
| Doyle Thomas F |
VP Strategic Initiatives |
• • – |
2014-01-21 |
4 |
OE |
$5.91 |
$627,870 |
D/D |
59,645 |
112,089 |
|
- |
|
| Wolf John Peter Iii |
VP, General Counsel |
• • – |
2014-01-17 |
4 |
OE |
$5.91 |
$794,817 |
D/D |
69,785 |
110,768 |
|
- |
|
| Milano Vincent |
President and CEO |
• • – |
2014-01-17 |
4 |
OE |
$3.14 |
$686,213 |
D/D |
79,126 |
482,281 |
|
- |
|
| Rowland Charles A Jr |
VP, Chief Financial Officer |
• • – |
2014-01-08 |
4 |
D |
$49.80 |
$321,160 |
D/D |
(6,449) |
87,026 |
|
- |
|
| Rowland Charles A Jr |
VP, Chief Financial Officer |
• • – |
2014-01-08 |
4 |
OE |
$5.91 |
$273,157 |
D/D |
28,753 |
87,584 |
|
- |
|
| Soland Daniel B |
VP, Chief Operating Officer |
• • – |
2014-01-08 |
4 |
D |
$49.80 |
$214,489 |
D/D |
(4,307) |
153,332 |
|
- |
|
| Soland Daniel B |
VP, Chief Operating Officer |
• • – |
2014-01-08 |
4 |
OE |
$5.91 |
$182,222 |
D/D |
19,289 |
153,890 |
|
- |
|
| Pietrusko Robert |
VP, Regulatory & Quality |
• • – |
2014-01-08 |
4 |
D |
$49.80 |
$572,102 |
D/D |
(11,488) |
70,877 |
|
- |
|
| Pietrusko Robert |
VP, Regulatory & Quality |
• • – |
2014-01-08 |
4 |
OE |
$5.91 |
$498,154 |
D/D |
45,837 |
74,194 |
|
- |
|
| Broom Colin Md |
VP & Chief Scientific Officer |
• • – |
2014-01-08 |
4 |
D |
$49.80 |
$1,002,972 |
D/D |
(20,140) |
154,058 |
|
- |
|
| Broom Colin Md |
VP & Chief Scientific Officer |
• • – |
2014-01-08 |
4 |
OE |
$1.84 |
$740,574 |
D/D |
142,142 |
156,192 |
|
- |
|
| Brooke Paul A |
Director |
• • – |
2014-01-07 |
4 |
D |
$49.89 |
$34,225 |
D/D |
(686) |
128,314 |
|
- |
|
| Brooke Paul A |
Director |
• • – |
2014-01-07 |
4 |
OE |
$3.42 |
$34,200 |
D/D |
10,000 |
129,000 |
|
- |
|
| Milano Vincent |
President and CEO |
• • – |
2014-01-06 |
4 |
OE |
$3.55 |
$143,097 |
D/D |
40,309 |
403,155 |
|
- |
|
| Mchugh Julie |
Director |
• • – |
2014-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,083 |
8,666 |
|
- |
|
| Pietrusko Robert |
VP, Regulatory & Quality |
• • – |
2013-12-27 |
4 |
D |
$49.86 |
$36,149 |
D/D |
(725) |
36,528 |
|
- |
|
412 Records found
|
|
Page 2 of 17 |
|
|
